Table VII.
Univariate analysis and multivariate analysis of amplified genes in gastric cancer for overall survival.
| Univariate analysis | Multivariate analysis | |||||
|---|---|---|---|---|---|---|
| Variable | HR | P-value | 95% CI | HR | P-value | 95% CI |
| CCNE1 | 2.190 | 0.035 | 1.058–4.535 | 1.891 | 0.101 | 0.883–4.054 |
| Normal vs. abnormal | ||||||
| MYC | 1.468 | 0.472 | 0.515–4.186 | |||
| Normal vs. abnormal | ||||||
| CDK6 | 3.996 | 0.013 | 1.333–11.983 | |||
| Normal vs. abnormal | ||||||
| EGFR | 21.235 | 0.475 | 0.005–92105.54 | 3.071 | 0.054 | 0.983–9.593 |
| Normal vs. abnormal | ||||||
| KRAS | 2.279 | 0.260 | 0.544–9.550 | |||
| Normal vs. abnormal | ||||||
HR, hazard ratio; CI, confidence interval.